The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects
Clinical trial NCT06044467 · COMPLETED
Trial details
- NCT number
- NCT06044467
- Sponsor
- ChemomAb Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-11
- Primary completion
- 2020-04-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.